Medical devices

Professor Andrew Lewis

Director of Research and Development at Biocompatibles UK Ltd.


Andrew Lewis specialises in the development of advanced biomedical polymer systems, which have been applied to novel drug-device combination products for the treatment of cardiovascular disease and cancer. He was co-inventor of the Drug Eluting Bead, a novel drug delivery system which is available in over 600 hospitals in 50 different countries, with over 100,000 reported procedures to date. This product won the PLC Best Technology Award in 2003 and in 2011 was further recognised by the Prince Philip Award for Plastics in the Service of Mankind He has published over 200 papers and contributed chapters to many textbooks, including Biomaterials for Cancer Therapeutics (2013), Tumors of the Central Nervous System (2012) and Handbook of Stents (2001).


Dr Yasmin Buchaekert

Yasmin originally trained as a vet before embarking on a successful research career. She studied under the world-renowned pulmonologist, Prof. Werner Seeger, at the University of Giessen, GErmany. Here she completed her PhD as part of a graduate programme concentrating on molecular biology and medicine of the lung. Yasmin’s research focus was ARDS/Acute Lung Injury. Along the way she spoke at prestigious meetings, worked on high-profile projects and co-authored a number of interesting publications.

Following completion of her PhD, Yasmin moved to the commercial world, first working in the field of oral and maxillofacial surgery where she led a team developing innovative products made from human bone transplants.  The goal was to bring to market minimal invasive bone augmentation techniques which did not necessitate autografting. Subsequently, Yasmin moved to internal medicine/oncology at Epigenomics. Here her role is to inform healthcare professional across Europe as to the potential benefits of new biotechnologies, notably liquid biopsy, for the early diagnosis of cancer.


Jon Pike 

Jon joined Medtronic in October 2008 leading the communications function for Medtronic UK & Ireland. Since then Jon has been involved in numerous product launches, established strong relationships with media on behalf of the company, developed partnerships with press teams in hospitals across the UK & Ireland and overseen the development of a social media presence for the company. During his time with the company, the Medtronic team has received the Communique Award (healthcare PR and medical education awards) for In House Team of the Year on two occasions.

In addition to UK & Ireland communications responsibilities he also has PR responsibilities for the Neuromodulation business in EMEAC and also for Hospital Solutions.

Jon has over 15 years of experience in healthcare PR and communications manaing media campaigns for many prescription drugs, Over The Counter treatments and developed disease awareness campaigns for many of the major pharmaceutical companies.

He worked with PR agencies in London and Sydney before setting up on his own supporting clients like the National Rheumatoid Arthritis Society (NRAS), the ABPI and organising the annual Ask About Medicines campaign with the Department of Health.

Jon has BA hons degree in History from the University of Warwick and a Masters in European Industrial Relations from Warwick Business School.


Prof Annie Young

Professor of Nursing, Warwick Medical School


Annie is Professor of Nursing at Warwick Medical School, working clinically in University Hospitals Coventry and Warwickshire. Her research portfolio encompasses the management of thrombosis in cancer patients, symptomatic care including prevention of chemotherapy-associated alopecia and nausea and vomiting.  Rehabilitation for cancer patients and new technologies for monitoring side effects of cancer therapies are special interests; Annie is a member of the NCRI Supportive and Palliative Care Clinical Studies Group. She also teaches oncology nursing in sub-Saharan Africa, alongside local nurses.


Professor Hartmut Gemmeke

Karlsruhe Institute of Technology

Prof. Dr. Hartmut Gemmeke was born in Northeim, Germany, on March 9th, 1944. He received his Ph.D. degree and postdoctoral lecture qualification from the University of Heidelberg, Germany, in 1971 and 1979 respectively. After two years, with the University of Marburg, Germany, he joined 1982 Forschungszentrum Karlsruhe (FZK), where he worked several years on the planning and commissioning of the KARMEN neutrino experiment at Rutherford Appleton Laboratory, England. Since 1990, he was a supernumerary professor at the University of Heidelberg and 1996 at the University of Karlsruhe. 1993 he was head of the Central Department of Electronics and Data Processing at FZK and since 2001, appointed as director to the Institute for Data Processing and Electronics at FZK, now Karlsruhe Institute of Technology (KIT). He was member and head of several committees on electronics, micro system technology, and data processing in Germany and IEEE (RT). He has about 400 publications including 50 in medical engineering. He is now retired and works as senior advisor at the KIT.

His present research activities are focused on the investigation of 3D Ultra Sound Computer-Tomography for early breast cancer detection.


Professor Abhay Pandit

National University of Ireland, Galway

Professor Abhay Pandit is the Director of a Centre for Research in Medical Devices (CÚRAM) at the National University of Ireland, Galway. Professor Pandit is one of the world leaders in developing new biomaterials for use in medical devices. The focus of Professor Pandit’s lab is to develop new biomaterials combining synthetic and natural polymers, tailored glycomolecules, small molecules nucleic acids targeting systems and cellular elements for use in structures that can be used in a wide range of surgery and therapy. A key area of his work regards biodegradable materials which will be absorbed into the body over time.  The areas of medicine involved are very diverse, ranging from cardiology to neurology and is increasing over time. He has led in the development of targeted controlled-drug-release systems, multi-component biomaterial-based selective delivery systems and the synthesis of electrically responsive materials. He is the author of 4 patents with 18 other patent applications pending and has licensed three technologies to medical device companies. Prof. Pandit has also authored nearly 200 papers in high-impact journals such as Nature Communications and is a member of the editorial board of 13 journals. Some of Professor Pandit’s work has included: ~A polymer for transfecting a nucleic acid into a cell ~Collagen multichannel nerve conduits for use in the repair of nerve injury. ~A polymeric hollow nanosphere for release of biomolecules, therapeutic agents and ~Principal investigator for a tissue-engineered heart valve project. He is the director of the 'Network of Excellence for Functional Biomaterials - a Science Foundation Ireland Strategic Research Cluster